Ketamine / KAPPending re-verificationDesignated-centers model

Psychiatrische Universitätsklinik Zürich (PUK) - private services

Zürich, Switzerland

Treatment & access

  • Treatments offeredS-ketamine (Spravato) treatment · Racemic ketamine treatment · Second Opinion consultation for difficult-to-treat depression · Diagnostic workup (EEG, laboratory, imaging as needed)
  • Access routeprivate_pay
  • Price informationPUK states that ketamine treatment costs may be covered by the health insurer (less franchise and deductible); for S-ketamine (Spravato) a prior cost approval (Kostengutsprache) from the insurer is required, requested via the patient's psychiatrist. No prices are published on the provider's website.
  • Phone+41 58 384 21 11
  • Websitehttps://pukzh.ch

About this provider

The Psychiatrische Universitätsklinik Zürich (PUK) offers treatment with the approved medication S-ketamine (Spravato) and with racemic ketamine for adults with treatment-resistant depression, defined as at least two adequate failed treatment attempts in the current episode. The programme runs through the Second Opinion Depression outpatient service and includes a preliminary consultation for indication assessment, exclusion of medical contraindications, joint definition of therapy goals and diagnostic workup such as EEG. Courses are time-limited, typically two treatments per week for one month followed by one per week for a further month, and can be delivered on an outpatient basis. Every administration includes two hours of medical and nursing monitoring of vital parameters with full safety measures.

Services & programs

  • Ketamine and S-ketamine treatment for treatment-resistant depressionTime-limited courses with S-ketamine (Spravato) or racemic ketamine, typically 2 treatments/week for one month plus 1 treatment/week for a second month, available on an outpatient basis, with two-hour medical and nursing monitoring of vital parameters (including cardiopulmonary resuscitation readiness) before, during and after each administration. May be covered by the health insurer less franchise and deductible; prior insurer cost approval required for S-ketamine. No prices published.
  • Second Opinion Depression consultationSpecialist outpatient consultation for difficult-to-treat depression: indication assessment, exclusion of contraindications, definition of therapy goals, review of further treatment options and patient education on mechanism and side effects. Not published on the provider's website.
  • Diagnostic examinationsNecessary diagnostics prior to treatment, including electroencephalogram and, where indicated, laboratory tests or imaging. Not published on the provider's website.

Programs & studies

ProgramKindStatus
S-ketamine (Spravato) treatment
PUK describes Spravato as the approved preparation; prior cost approval from the health insurer is required before treatment.
esketamine_nasaloffered
Racemic ketamine treatment
Offered alongside S-ketamine for treatment-resistant depression; costs may under certain circumstances be covered by the insurer.
ketamineoffered

Pricing

ItemPrice
Ketamine / S-ketamine treatment
PUK states costs may be covered by the health insurer less franchise and deductible; S-ketamine requires prior insurer cost approval, which the clinic can help arrange.
Not published

Prices are taken from the provider's own website and were last checked on . Always confirm the current price with the provider before booking.

Facilities & languages

  • LanguagesProvider website is published in German.
  • TeamThe treatment team consists of psychiatrists and nursing professionals; the clinic also trains staff from medical, nursing and therapeutic fields who are integrated into the treatment team.

Common questions

Are ketamine treatments at PUK covered by Swiss health insurance?

According to PUK, costs for ketamine treatment may under certain circumstances be covered by the health insurer, minus franchise and deductible. For S-ketamine (Spravato), a prior cost approval from the insurer is required, which should be requested through your treating psychiatrist; PUK can assist with this.

How do I get referred?

Registration is handled by the Second Opinion Depression outpatient service exclusively by e-mail. A referral letter from your psychiatrist must be enclosed, detailing previous treatment attempts including type, duration and maximum dose of prior medication.

Who is eligible?

Patients with treatment-resistant depression, meaning at least two adequate treatment attempts have failed during the current episode. A preliminary consultation checks the indication and excludes medical contraindications.

Is the treatment inpatient or outpatient?

The treatment course can be carried out on an outpatient basis, typically two sessions per week for one month followed by one per week for another month. The outpatient service is closely networked with PUK's inpatient and day-clinic depression services.

What happens during each session?

Each administration of S-ketamine or ketamine is accompanied by two hours of medical and nursing monitoring of vital parameters, with safety measures including cardiopulmonary resuscitation readiness before, during and after the treatment.

Looking at alternatives? Other Swiss routes for comparable treatment include BAG-designated centres administering esketamine (Spravato), providers holding case-by-case federal authorisations under the limited medical use programme for psychedelic-assisted therapy, and participation in clinical trials at university centres.

Verification

This record was verified previously and is awaiting its scheduled re-check against the registry.

  • License / registryPublic trial registry (ClinicalTrials.gov / EU CTIS)
  • Sourcehttps://pukzh.ch
  • Last verified

Spotted an error? See our methodology for how records are checked and how to report a correction.